NIAID awards $28.6M contract for clinical site monitoring, with PPD Development LP as the contractor

Contract Overview

Contract Amount: $28,578,960 ($28.6M)

Contractor: PPD Development LP

Awarding Agency: Department of Health and Human Services

Start Date: 2022-06-30

End Date: 2026-06-29

Contract Duration: 1,460 days

Daily Burn Rate: $19.6K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 5

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)

Place of Performance

Location: WILMINGTON, NEW HANOVER County, NORTH CAROLINA, 28401

State: North Carolina Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $28.6 million to PPD DEVELOPMENT LP for work described as: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) Key points: 1. Contract focuses on research and development in life sciences, aligning with NIH's mission. 2. Full and open competition suggests a robust bidding process. 3. Cost-plus-fixed-fee contract type may incentivize cost control by the contractor. 4. Contract duration of 4 years provides stability for critical research support. 5. Performance is located in North Carolina, impacting the regional research ecosystem. 6. The contract value is moderate within the context of large-scale federal R&D investments.

Value Assessment

Rating: good

The contract value of $28.6 million over four years for clinical site monitoring appears reasonable for the scope of work. Benchmarking against similar contracts for R&D support services by NIAID or other NIH institutes would provide a more precise value-for-money assessment. The cost-plus-fixed-fee structure, while common, requires careful monitoring to ensure costs remain within projections and the fixed fee is justified by the services rendered. Without specific performance metrics or detailed cost breakdowns, a definitive assessment of exceptional value is difficult, but the contract appears to be fairly priced for the services described.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

This contract was awarded under full and open competition, indicating that all responsible sources were permitted to submit a bid. The presence of 5 bidders suggests a healthy level of competition for this type of specialized research support service. A competitive process like this generally leads to better price discovery and encourages contractors to offer competitive terms and pricing to win the award. The agency's decision to use full and open competition implies confidence that a sufficient number of qualified vendors exist in the market.

Taxpayer Impact: Taxpayers benefit from a competitive process that is likely to result in a more cost-effective award compared to sole-source or limited competition contracts. This approach helps ensure that federal funds are used efficiently by driving down prices and improving the quality of services received.

Public Impact

The primary beneficiaries are the National Institutes of Health (NIH) and its research initiatives, specifically those managed by the National Institute of Allergy and Infectious Diseases (NIAID). The contract will support critical clinical research by ensuring the quality, integrity, and reliability of data collected at clinical trial sites. Services will be delivered primarily in North Carolina, potentially creating or sustaining jobs in the local research and administrative support sectors. The contract enables the advancement of medical research, potentially leading to new treatments and therapies for various diseases.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for cost overruns in cost-plus-fixed-fee contracts if not rigorously managed.
Dependence on a single contractor for critical monitoring services could pose a risk if performance falters.
The specific expertise required for clinical site monitoring may limit the pool of truly qualified subcontractors.

Positive Signals

Full and open competition suggests a strong market exists for these services, indicating potential for high-quality vendor selection.
The fixed fee component of the contract provides a degree of cost certainty for the government.
A 4-year contract duration allows for continuity and stability in supporting ongoing research projects.

Sector Analysis

This contract falls within the Research and Development sector, specifically focusing on clinical trial support services. The market for clinical research organizations (CROs) and site monitoring services is substantial, driven by the pharmaceutical and biotechnology industries, as well as government health agencies. NIAID's spending on such services is crucial for advancing its mission in infectious disease research. Comparable spending benchmarks would typically be found within NIH's broader R&D service procurements and the overall federal spending on clinical trial management.

Small Business Impact

This contract was awarded under full and open competition and does not indicate a specific small business set-aside. While the prime contractor, PPD Development LP, is a large entity, there may be opportunities for small businesses to participate as subcontractors. The extent of small business subcontracting will depend on the prime contractor's strategy and the specific needs of the clinical site monitoring services. Further analysis of the subcontracting plan would be needed to assess the direct impact on the small business ecosystem.

Oversight & Accountability

Oversight for this contract will likely be managed by contracting officers and program officials within NIAID and the NIH. The cost-plus-fixed-fee structure necessitates diligent financial oversight to ensure costs are reasonable and allocable. Performance monitoring will be crucial to ensure the contractor meets the defined objectives and deliverables. Transparency is generally maintained through contract award databases, though detailed performance reports are typically internal. Inspector General jurisdiction would apply in cases of fraud, waste, or abuse.

Related Government Programs

NIH Clinical Center Support Services
NIAID Research and Development Contracts
Federal Clinical Trial Management Services
Biomedical Research Support Contracts
Life Sciences R&D Services

Risk Flags

Cost-plus-fixed-fee contract type requires diligent oversight to manage costs.
Dependence on a single contractor for critical monitoring functions.
Potential for performance issues impacting research integrity if not managed effectively.

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $28.6 million to PPD DEVELOPMENT LP. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)

Who is the contractor on this award?

The obligated recipient is PPD DEVELOPMENT LP.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $28.6 million.

What is the period of performance?

Start: 2022-06-30. End: 2026-06-29.

What is the track record of PPD Development LP with federal contracts, particularly with NIH or NIAID?

PPD Development LP, a subsidiary of Thermo Fisher Scientific, has a significant history of federal contracting, including numerous awards from agencies like the NIH, FDA, and CDC. Their experience spans various research and development support services, clinical trial management, and data analysis. While specific details on past performance metrics for this exact type of contract with NIAID are not publicly itemized in this summary, their extensive portfolio suggests a substantial capacity and familiarity with government research requirements. A deeper dive into their contract history, including any past performance evaluations or disputes, would be necessary for a comprehensive assessment of their track record.

How does the $28.6 million contract value compare to similar NIAID clinical site monitoring contracts?

The $28.6 million contract value over four years for clinical site monitoring by NIAID represents an average annual value of approximately $7.15 million. To benchmark this effectively, one would need to compare it against the average value and duration of other NIAID or NIH contracts for similar clinical site monitoring services. Factors such as the complexity of the trials, geographic scope, and specific services required (e.g., data management, regulatory compliance, patient recruitment support) can significantly influence contract values. Without access to a comprehensive database of comparable NIAID contracts, it's challenging to definitively state if this represents a high, low, or average investment, but it appears to be a substantial commitment for specialized research support.

What are the primary risks associated with this Cost Plus Fixed Fee (CPFF) contract type for NIAID?

The primary risk for NIAID with a Cost Plus Fixed Fee (CPFF) contract is the potential for the contractor to incur costs exceeding initial estimates, even though the fee is fixed. While the fixed fee incentivizes the contractor to manage costs to maximize their profit margin on that fee, there's less direct incentive to reduce the overall cost base compared to fixed-price contracts. NIAID must therefore implement robust oversight to scrutinize allowable costs, ensure efficiency, and prevent scope creep that could inflate the total contract cost. The agency also bears the risk of cost overruns if the contractor's cost projections are inaccurate or if unforeseen circumstances drive up expenses, although the fixed fee itself remains constant.

How effective is full and open competition in ensuring value for money in specialized R&D support services?

Full and open competition is generally considered the most effective method for ensuring value for money in specialized R&D support services. By allowing all qualified vendors to bid, it fosters a competitive environment that drives down prices and encourages innovation. The presence of five bidders in this case suggests that the market is sufficiently robust to support such competition. This process allows the agency to compare multiple proposals based on technical merit and price, leading to the selection of the best overall value. While effective, the agency must still conduct thorough evaluations to ensure the lowest price doesn't compromise quality or technical capability.

What are the potential workforce implications of this contract in North Carolina?

This contract is likely to have positive workforce implications in North Carolina, a state with a growing life sciences sector. PPD Development LP, as the contractor, will require a team of professionals to manage and execute clinical site monitoring. This could include clinical research associates, project managers, data managers, regulatory specialists, and administrative support staff. The presence of these jobs contributes to the local economy and strengthens the state's position as a hub for biomedical research and clinical trial operations. The duration of the contract also suggests potential for stable, long-term employment opportunities within these specialized fields.

What are the key performance indicators (KPIs) likely used to measure the success of this contract?

Key performance indicators (KPIs) for this contract would likely focus on the quality, timeliness, and compliance of clinical site monitoring. Examples include: adherence to study protocols and Good Clinical Practice (GCP) guidelines, accuracy and completeness of data collected, timeliness of site visits and monitoring reports, identification and resolution of site issues, and overall compliance with regulatory requirements. The success of the contractor will also be measured by their ability to manage the budget effectively within the cost-plus-fixed-fee structure and maintain open communication with NIAID. Performance metrics are crucial for ensuring the integrity of the research data generated.

Industry Classification

NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: 75N93020R00021

Offers Received: 5

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Address: 929 N FRONT ST, WILMINGTON, NC, 28401

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $28,578,960

Exercised Options: $28,578,960

Current Obligation: $28,578,960

Actual Outlays: $24,260,833

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Timeline